The crisis of opioid addiction in the US is no longer something employers can afford to ignore. A growing body of research points to opioids as a significant factor in the hollowing out of the US workforce, particularly among prime-aged men. We’ve also heard many stories in recent years about employers having difficulty hiring for safety-sensitive roles in certain geographies because of the lack of qualified candidates able to pass a mandatory drug test.
So for most US businesses, opioid addiction is an issue that affects both their workforce and their talent pool, and employers who find ways to support workers affected by it are doing both economic and social good. Phil Albinus thinks through some of the ways employers can help at Employee Benefit News:
There could be an increase in benefits like telemedicine services, which would broaden the reach of medical treatment to rural areas where doctors are often in short supply. In addition, employers (if they have not already done so) may review service coverage for behavioral health and/or employee assistance program needs. An evaluation of the behavioral health portions of health insurance policies and EAP contracts will help to ensure employees are covered for abuse of prescription drugs. …
Dennis Yip/Flickr/Public Domain
In a paper last year on the disappearance of many prime-age men from the US workforce, Princeton economist Alan Krueger presented the unsettling finding that 44 percent of working-age men who were not in the labor force reported taking pain medication on a regular basis, and two-thirds of these men were taking prescription pain medication. While improvements in video game technology may be contributing to these men’s lower workforce participation by making long-term unemployment more bearable, Krueger wrote, their high rates of poor health and use of narcotic painkillers are much more disconcerting.
In the Fall 2017 edition of the Brookings Papers on Economic Activity, Krueger publishes an update of that research with new data, homing in on the impact of opioid epidemic on the labor market. That impact, he finds, is even more significant than previously thought, accounting for some 20 percent of the decrease in men’s labor force participation between 1999 and 2015, and 25 percent of the decrease among women, Brookings editor Fred Dews explains:
Krueger’s paper suggests that, though much of the decline can be attributed to an aging population and other trends that pre-date the Great Recession (for example, increased school enrollment of younger workers), an increase in opioid prescription rates might also play an important role in the decline, and undoubtedly compounds the problem as many people who are out of the labor force find it difficult to return to work because of reliance on pain medication.
Quest Diagnostics’ Drug Testing Index, which analyzed some 11 million workplace drug test results, found that the percentage of US employees who tested positive for drugs hit a ten-year high in 2015:
Insights from the 2015 data show that the positivity rate for 9.5 million urine drug tests in the combined U.S. workforce increased to four percent, a relative change of 2.6 percent over the positivity rate in 2014 (4.0% versus 3.9%). The 2015 positivity rate reflects a relative increase of 14 percent over the 10-year low of 3.5 percent observed in both 2010 and 2011. The last year that the positivity rate for urine drug tests in the combined U.S. workforce was at or above four percent was 2005, when it reached 4.1 percent. …
In oral fluid drug testing, the overall positivity rate increased 47 percent over the last three years in the general U.S. workforce to 9.1 percent in 2015 from 6.7 percent in 2013. The increase was largely driven by double-digit increases in marijuana positivity during this time period. In 2015, there was a 25 percent relative increase in marijuana detection as compared to 2014 (7.5% versus 6.0%). Slightly more than nine percent of oral fluid test results were positive for one or more drugs, suggesting that nearly one in eleven job applicants were unable to pass an oral fluid drug screen.
Among drug testing methods, overall positivity in the general U.S. workforce was highest in hair drug tests, at 10.3 percent in 2015, a seven percent increase over 2014 (9.6%) Because hair testing shows repetitive drug use as far back as 90 days, it can give a more complete drug-use history.
The Wall Street Journal’s Lauren Weber hears more from the Quest director in charge of the analysis about which drugs employees have been using—you can probably guess which one is the most common: